Who Exports Terbutaline from India — 98 Suppliers Behind a $3.5M Market
India's terbutaline export market is supplied by 98 active exporters who collectively shipped $3.5M across 297 shipments. UMAVIDA PHARMA PRIVATE LIMITED leads with a 63.5% market share, followed by MCW HEALTHCARE PRIVATE LIMITED and CROIENT PHARMA PRIVATE LIMITED. The top 5 suppliers together control 76.9% of total export value, reflecting a concentrated market structure.
Top Terbutaline Exporters from India — Ranked by Export Value
UMAVIDA PHARMA PRIVATE LIMITED is the leading terbutaline exporter from India, holding a 63.5% share of the $3.5M market across 297 shipments from 98 exporters. The top 5 suppliers — UMAVIDA PHARMA PRIVATE LIMITED, MCW HEALTHCARE PRIVATE LIMITED, CROIENT PHARMA PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, AHAAN HEALTHCARE PRIVATE LIMITED — collectively control 76.9% of total export value, indicating a highly concentrated market. Individual shares are: UMAVIDA PHARMA PRIVATE LIMITED (63.5%), MCW HEALTHCARE PRIVATE LIMITED (4.4%), CROIENT PHARMA PRIVATE LIMITED (3.2%), ZYDUS LIFESCIENCES LIMITED (3.0%), AHAAN HEALTHCARE PRIVATE LIMITED (2.7%).
Top Terbutaline Exporters from India
Ranked by export value · 98 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | UMAVIDA PHARMA PRIVATE LIMITED TERBUTALINE SULPHATE, BROMHEXINE HYDROCHMEDI-TOSSE SYRUP TERBUTALINE, BROMEXINE, | $2.2M | 1 | 63.5% |
| 2 | MCW HEALTHCARE PRIVATE LIMITED TERBUTALINE SYRUP 1.5MG/5ML TERBUTALINETERASH 2 5 TABLETS TERBUTALINE TABLETSBP 2 5MGTERASH 2.5 TABLETS | $154.0K | 1 | 4.4% |
| 3 | CROIENT PHARMA PRIVATE LIMITED GUAMEN | $113.0K | 1 | 3.2% |
| 4 | ZYDUS LIFESCIENCES LIMITED MUCOSIL AM SYRUP 1X100MLMUCOSIL AM SYRUP 100ML (TERBUTALINE SULF | $104.9K | 2 | 3.0% |
| 5 | AHAAN HEALTHCARE PRIVATE LIMITED GUAMEN | $95.3K | 4 | 2.7% |
| 6 | SCOTT EDIL PHARMACIA LIMITED | $83.6K | 3 | 2.4% |
| 7 | G J PHARMACEUTICALS LLP TURCOF EXPECTORANT (TERBUTALINE 2.5 MG BTABZ-BRONCHOCLEARTABZ-BRONCHOCLEAR (TERBUTALINE SULPHATE | $76.7K | 1 | 2.2% |
| 8 | BAFNA PHARMACEUTICALS LIMITED TERBUTALINE SYRUP 1.5MG/5ML TERBUTALINETERASH 2 5 TABLETS TERBUTALINE TABLETSBP 2 5MGTERASH 2.5 TABLETS | $65.7K | 1 | 1.9% |
| 9 | GEMSHI PHARMACEUTICALS PRIVATE LIMITED TURCOF EXPECTORANT (TERBUTALINE 2.5 MG B | $46.1K | 1 | 1.3% |
| 10 | CADILA HEALTHCARE LIMITED MUCOSIL AM SYRUP 1X100MLMUCOSIL AM SYRUP 100ML (TERBUTALINE SULF | $44.3K | 2 | 1.3% |
| 11 | ACIES PHARMACEUTICAL PRIVATE LIMITED | $27.8K | 2 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Terbutaline exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| ZYDUS LIFESCIENCES LIMITED | Approved | Yes, as of May 26, 2 | No | Data not available | Formerly known as Cadila Healthcare Limited; WHO-GMP certified for API manufactu |
| SCOTT EDIL PHARMACIA LIMITED | Not Listed | Yes, as of January 2 | No | Data not available | WHO-GMP certified for manufacturing at Unit-II facility. |
TransData Nexus reviewed the regulatory standing of 2 leading Terbutaline exporters from India. 1 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Terbutaline sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the nation's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and intermediates. Notable firms include A.R. Life Sciences, which manufactures a wide range of APIs for various treatments, and Hy-Gro Chemicals, focusing on cost-effective API development. This robust infrastructure positions Hyderabad as a key player in the production of Terbutaline and similar bulk drugs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Vadodara, in particular, is home to companies like Mercury Laboratories Limited, which has been manufacturing pharmaceutical products for over five decades. Additionally, the region hosts numerous pharmaceutical companies, contributing significantly to the state's pharmaceutical output. This concentration of formulation expertise makes the region pivotal in the production of Terbutaline formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Companies like Formel Labs, with facilities in Mumbai and Hyderabad, are committed to producing safe and effective medicines, ensuring that products like Terbutaline meet international standards. The region's strategic location and well-established logistics infrastructure facilitate efficient export operations, making it a vital hub for distributing pharmaceuticals globally.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is recognized for its tax incentives, attracting numerous pharmaceutical manufacturers. Companies like Theon Pharma, based in Baddi, offer contract manufacturing services across India, including Gujarat. This region's favorable tax policies and manufacturing capabilities make it an attractive option for producing cost-effective Terbutaline formulations.
5Sourcing Recommendations
- Diversify Supplier Base: While UMAVIDA PHARMA PRIVATE LIMITED accounts for 63.5% of Terbutaline exports, engaging with other suppliers can mitigate risks associated with over-reliance on a single source.
- Leverage Regional Strengths: Utilize Hyderabad's API production capabilities for bulk Terbutaline and Ahmedabad-Vadodara's expertise for formulations to optimize the supply chain.
- Optimize Export Logistics: Capitalize on the Mumbai-Thane-Raigad region's export infrastructure to ensure timely and efficient global distribution of Terbutaline products.
- Explore Cost Advantages: Consider manufacturing in the Baddi-Nalagarh tax incentive zone to reduce production costs, enhancing competitiveness in the Terbutaline market.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can enhance its supply chain resilience and capitalize on regional strengths in Terbutaline production and export.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Terbutaline exporters from India
Zydus Lifesciences Limited — Zydus acquires 50% stake in Sterling Biotech Limited
Zydus Lifesciences Limited, through its wholly owned subsidiary, acquired a 50% equity stake in Sterling Biotech Limited (SBL). SBL specializes in gelatin, di-calcium phosphate, and select active pharmaceutical ingredients, operating two manufacturing facilities in Gujarat. This acquisition marks Zydus's entry into specialized biotech products for health and nutrition. - IMPACT: The acquisition is expected to enhance Zydus's production capabilities, potentially increasing Terbutaline export volumes.
Impact: The acquisition is expected to enhance Zydus's production capabilities, potentially increasing Terbutaline export volumes.
Zydus Lifesciences Limited — Zydus receives USFDA approval for prostate cancer drug
Zydus Lifesciences received approval from the U.S. Food and Drug Administration (USFDA) to manufacture enzalutamide tablets, used for treating prostate cancer. The product will be manufactured at Zydus's facility in Ahmedabad. - IMPACT: While this approval pertains to oncology, it may lead to increased production capacity, indirectly benefiting Terbutaline exports.
Impact: While this approval pertains to oncology, it may lead to increased production capacity, indirectly benefiting Terbutaline exports.
Zydus Lifesciences Limited — Zydus acquires Checkpoint Therapeutics for $355 million
Zydus Lifesciences acquired Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This acquisition expands Zydus's portfolio, potentially leading to increased production capabilities that could positively affect Terbutaline exports.
Impact: This acquisition expands Zydus's portfolio, potentially leading to increased production capabilities that could positively affect Terbutaline exports.
Common Questions — Terbutaline Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which terbutaline supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, UMAVIDA PHARMA PRIVATE LIMITED leads with 8 recorded shipments worth $2.2M. MCW HEALTHCARE PRIVATE LIMITED (27 shipments) and CROIENT PHARMA PRIVATE LIMITED (11 shipments) are also established high-volume exporters.
Q How many terbutaline manufacturers are there in India?
India has 98 active terbutaline exporters with a combined export market of $3.5M across 297 shipments to 59 countries. The top 5 suppliers hold 76.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for terbutaline from India?
Average FOB unit price: $2.90 per unit, ranging from $0.05 to $262.29. Average shipment value: $11.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 98 verified Indian exporters of Terbutaline ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 297 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 59 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
297 Verified Shipments
98 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists